Ligand Pharmaceuticals (LGND) Gross Profit Growth (1y) (2011 - 2026)
Ligand Pharmaceuticals (LGND) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 68.41% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 5.92 Bn | 5.14 Bn | 48.45 Mn | 19.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.67% |
| Dec 31, 2025 | 41.77% |
| Sep 30, 2025 | 126.20% |
| Jun 30, 2025 | 15.78% |
| Mar 31, 2025 | 44.09% |
| Dec 31, 2024 | 51.08% |
| Sep 30, 2024 | 68.00% |
| Jun 30, 2024 | 56.40% |
| Mar 31, 2024 | -30.22% |
| Dec 31, 2023 | -8.02% |
| Sep 30, 2023 | -34.80% |
| Jun 30, 2023 | -34.60% |
| Mar 31, 2023 | 26.54% |
| Dec 31, 2022 | -35.24% |
| Sep 30, 2022 | -6.59% |
| Jun 30, 2022 | -21.75% |
| Mar 31, 2022 | -17.23% |
| Dec 31, 2021 | -23.74% |
| Sep 30, 2021 | 35.93% |
| Jun 30, 2021 | 42.89% |